Literature DB >> 15338048

Functional links between transcription, DNA repair and apoptosis.

P Berardi1, M Russell, A El-Osta, K Riabowol.   

Abstract

DNA damage initiates damage response pathways, cell cycle arrest and apoptosis. These processes act in a concerted fashion and remain functionally linked through mechanisms not completely understood. Programmed cell death, referred to as apoptosis, is a tightly regulated phenomenon ensuring that cells that accumulate irreversible DNA damage do not replicate. Interestingly, hyperacetylation of histone proteins, which alters transcription patterns and appears linked to DNA repair, also induces apoptosis, suggesting that aspects of chromatin modification link these very distinct processes. Modulating chromatin structure in the absence of any DNA lesions also activates key DNA damage-signalling proteins, further supporting the role of higher-order chromatin structure in mediating stress responses. This review will present an overview of the epigenetic control of eukaryotic genomes by chromatin remodelling as it pertains to DNA damage and highlight the potential role of the ING PHD proteins in linking apoptosis and DNA repair to gene transcription.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15338048     DOI: 10.1007/s00018-004-4179-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  13 in total

1.  Cardiac resynchronization in chronic heart failure.

Authors:  William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

2.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

Authors:  Michael R Bristow; Leslie A Saxon; John Boehmer; Steven Krueger; David A Kass; Teresa De Marco; Peter Carson; Lorenzo DiCarlo; David DeMets; Bill G White; Dale W DeVries; Arthur M Feldman
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

3.  Cardiac-resynchronization therapy for mild-to-moderate heart failure.

Authors:  Anthony S L Tang; George A Wells; Mario Talajic; Malcolm O Arnold; Robert Sheldon; Stuart Connolly; Stefan H Hohnloser; Graham Nichol; David H Birnie; John L Sapp; Raymond Yee; Jeffrey S Healey; Jean L Rouleau
Journal:  N Engl J Med       Date:  2010-11-14       Impact factor: 91.245

4.  Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association.

Authors:  Panos E Vardas; Angelo Auricchio; Jean-Jacques Blanc; Jean-Claude Daubert; Helmut Drexler; Hugo Ector; Maurizio Gasparini; Cecilia Linde; Francisco Bello Morgado; Ali Oto; Richard Sutton; Maria Trusz-Gluza
Journal:  Eur Heart J       Date:  2007-08-28       Impact factor: 29.983

5.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

Authors:  Michele Brignole; Angelo Auricchio; Gonzalo Baron-Esquivias; Pierre Bordachar; Giuseppe Boriani; Ole-A Breithardt; John Cleland; Jean-Claude Deharo; Victoria Delgado; Perry M Elliott; Bulent Gorenek; Carsten W Israel; Christophe Leclercq; Cecilia Linde; Lluís Mont; Luigi Padeletti; Richard Sutton; Panos E Vardas; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Paulus Kirchhof; Carina Blomstrom-Lundqvist; Luigi P Badano; Farid Aliyev; Dietmar Bänsch; Helmut Baumgartner; Walid Bsata; Peter Buser; Philippe Charron; Jean-Claude Daubert; Dan Dobreanu; Svein Faerestrand; David Hasdai; Arno W Hoes; Jean-Yves Le Heuzey; Hercules Mavrakis; Theresa McDonagh; Jose Luis Merino; Mostapha M Nawar; Jens Cosedis Nielsen; Burkert Pieske; Lidija Poposka; Frank Ruschitzka; Michal Tendera; Isabelle C Van Gelder; Carol M Wilson
Journal:  Eur Heart J       Date:  2013-06-24       Impact factor: 29.983

6.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

7.  Results of the Predictors of Response to CRT (PROSPECT) trial.

Authors:  Eugene S Chung; Angel R Leon; Luigi Tavazzi; Jing-Ping Sun; Petros Nihoyannopoulos; John Merlino; William T Abraham; Stefano Ghio; Christophe Leclercq; Jeroen J Bax; Cheuk-Man Yu; John Gorcsan; Martin St John Sutton; Johan De Sutter; Jaime Murillo
Journal:  Circulation       Date:  2008-05-05       Impact factor: 29.690

8.  Biventricular pacing for atrioventricular block and systolic dysfunction.

Authors:  Anne B Curtis; Seth J Worley; Philip B Adamson; Eugene S Chung; Imran Niazi; Lou Sherfesee; Timothy Shinn; Martin St John Sutton
Journal:  N Engl J Med       Date:  2013-04-25       Impact factor: 91.245

9.  Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial.

Authors:  Michele Brignole; Carlo Menozzi; Angel Moya; Dietrich Andresen; Jean Jacques Blanc; Andrew D Krahn; Wouter Wieling; Xulio Beiras; Jean Claude Deharo; Vitantonio Russo; Marco Tomaino; Richard Sutton
Journal:  Circulation       Date:  2012-05-07       Impact factor: 29.690

10.  Cardiac-resynchronization therapy for the prevention of heart-failure events.

Authors:  Arthur J Moss; W Jackson Hall; David S Cannom; Helmut Klein; Mary W Brown; James P Daubert; N A Mark Estes; Elyse Foster; Henry Greenberg; Steven L Higgins; Marc A Pfeffer; Scott D Solomon; David Wilber; Wojciech Zareba
Journal:  N Engl J Med       Date:  2009-09-01       Impact factor: 91.245

View more
  8 in total

Review 1.  The ING family tumor suppressors: from structure to function.

Authors:  Almass-Houd Aguissa-Touré; Ronald P C Wong; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-08-29       Impact factor: 9.261

Review 2.  Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control.

Authors:  B Shannan; M Seifert; D A Boothman; W Tilgen; J Reichrath
Journal:  J Mol Histol       Date:  2006-09-19       Impact factor: 2.611

Review 3.  The ING gene family in the regulation of cell growth and tumorigenesis.

Authors:  Andrew H Coles; Stephen N Jones
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

Review 4.  Cytogenetic perspective of ageing and longevity in men and women.

Authors:  E Zietkiewicz; A Wojda; M Witt
Journal:  J Appl Genet       Date:  2009       Impact factor: 3.240

5.  Cells from long-lived mutant mice exhibit enhanced repair of ultraviolet lesions.

Authors:  Adam B Salmon; Mats Ljungman; Richard A Miller
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-03       Impact factor: 6.053

6.  ING Genes Work as Tumor Suppressor Genes in the Carcinogenesis of Head and Neck Squamous Cell Carcinoma.

Authors:  Xiaohan Li; Keiji Kikuchi; Yasuo Takano
Journal:  J Oncol       Date:  2010-10-28       Impact factor: 4.375

7.  Defining the minimal peptide sequence of the ING1b tumour suppressor capable of efficiently inducing apoptosis.

Authors:  A Boyko; K Riabowol
Journal:  Cell Death Discov       Date:  2015-10-26

8.  Impact of combined treatment with nimesulide and cisplatin on oral carcinoma cells.

Authors:  Aleksandra Barac; Goran Mitulovic; Seth Hallström; Sonja Zehetmayer; Matthaeus Ch Grasl; Boban M Erovic
Journal:  Onco Targets Ther       Date:  2017-07-19       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.